ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

In Brief: Senate committee Oks Another Cigarette Tax Hike; NCI Seeking Cancer Control Science Head

August 1, 1986

CCOPs Payline Set At 211, Winners Lister; NCI Will Fund Only 51 Unless More Funds Added

March 16, 1990